List of International AIDS Vaccine Initiative patents

Patents where

Current Assignee

Name

International AIDS Vaccine Initiative

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8735542 HIV-1 clade a consensus sequences, antigens, and transgenes	Patent 8735542 was granted and assigned to International AIDS Vaccine Initiative on May, 2014 by the United States Patent and Trademark Office.		International AIDS Vaccine Initiative	United States Patent and Trademark Office	8735542	May 27, 2014
‌ US Patent 8119144 HIV-1 Clade A consensus sequences, antigens, and transgenes	Patent 8119144 was granted and assigned to International AIDS Vaccine Initiative on February, 2012 by the United States Patent and Trademark Office.		International AIDS Vaccine Initiative	United States Patent and Trademark Office	8119144	February 21, 2012
‌ US Patent 9347065 Methods to improve vector expression and genetic stability	Patent 9347065 was granted and assigned to International AIDS Vaccine Initiative on May, 2016 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	9347065	May 24, 2016
‌ US Patent 9944935 Methods to improve vector expression and genetic stability	Patent 9944935 was granted and assigned to International AIDS Vaccine Initiative on April, 2018 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	9944935	April 17, 2018
‌ US Patent 11014969 Tuberculosis compositions and methods of using the same	Patent 11014969 was granted and assigned to International AIDS Vaccine Initiative on May, 2021 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	11014969	May 25, 2021
‌ US Patent 9402894 Viral particles derived from an enveloped virus	Patent 9402894 was granted and assigned to International AIDS Vaccine Initiative on August, 2016 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	9402894	August 2, 2016
‌ US Patent 9562078 Methods for identifying broadly neutralizing antibodies utilizing recombinant HIV-1 envelope glycoproteins comprising stabilizing mutations	Patent 9562078 was granted and assigned to International AIDS Vaccine Initiative on February, 2017 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	9562078	February 7, 2017
‌ US Patent 9802986 Recombinant viral vectors	Patent 9802986 was granted and assigned to International AIDS Vaccine Initiative on October, 2017 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	9802986	October 31, 2017
‌ US Patent 10544430 Vesicular stomatitis virus and virus rescue system	Patent 10544430 was granted and assigned to International AIDS Vaccine Initiative on January, 2020 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	10544430	January 28, 2020
‌ US Patent 10202424 Recombinant viral vectors	Patent 10202424 was granted and assigned to International AIDS Vaccine Initiative on February, 2019 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	10202424	February 12, 2019
‌ US Patent 9925258 Replication-competent VSV-HIV Env vaccines	Patent 9925258 was granted and assigned to International AIDS Vaccine Initiative on March, 2018 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	9925258	March 27, 2018
‌ US Patent 10279027 Transgenic Vero-CD4/CCR5 cell line	Patent 10279027 was granted and assigned to International AIDS Vaccine Initiative on May, 2019 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	10279027	May 7, 2019
‌ US Patent 10428122 Tuberculosis compositions and methods of treating or preventing tuberculosis	Patent 10428122 was granted and assigned to International AIDS Vaccine Initiative on October, 2019 by the United States Patent and Trademark Office.		International AIDS Vaccine Initiative	United States Patent and Trademark Office	10428122	October 1, 2019
‌ US Patent 8105600 Method of inducing high-titer neutralizing antibody responses in a host by administering immune complexes comprising anti-HIV-1 Env antibodies and the HIV-1 Env	Patent 8105600 was granted and assigned to International AIDS Vaccine Initiative on January, 2012 by the United States Patent and Trademark Office.		International AIDS Vaccine Initiative	United States Patent and Trademark Office	8105600	January 31, 2012
‌ US Patent 9610346 Recombinant viral vectors	Patent 9610346 was granted and assigned to International AIDS Vaccine Initiative on April, 2017 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	9610346	April 4, 2017
‌ US Patent 10736953 Stable, spray dried, immunogenic, viral compositions		International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	10736953	August 11, 2020
‌ US Patent 10792357 Optimized HIV envelope gene and expression thereof		International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	10792357	October 6, 2020
‌ US Patent 8586056 HIV-1 envelope glycoprotein	Patent 8586056 was granted and assigned to International AIDS Vaccine Initiative on November, 2013 by the United States Patent and Trademark Office.		International AIDS Vaccine Initiative	United States Patent and Trademark Office	8586056	November 19, 2013
‌ US Patent 10844095 Recombinant viral vectors	Patent 10844095 was granted and assigned to International AIDS Vaccine Initiative on November, 2020 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	10844095	November 24, 2020
‌ US Patent 10220087 Optimized HIV envelope gene and expression thereof	Patent 10220087 was granted and assigned to International AIDS Vaccine Initiative on March, 2019 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	10220087	March 5, 2019
‌ US Patent 10081796 Neutralization-resistant CDV mutants and viral vectors	Patent 10081796 was granted and assigned to International AIDS Vaccine Initiative on September, 2018 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	10081796	September 25, 2018
‌ US Patent 10266574 Tuberculosis compositions and methods of using the same	Patent 10266574 was granted and assigned to International AIDS Vaccine Initiative on April, 2019 by the United States Patent and Trademark Office.		International AIDS Vaccine Initiative	United States Patent and Trademark Office	10266574	April 23, 2019
‌ US Patent 11891416 Recombinant viral vectors	Patent 11891416 was granted and assigned to International AIDS Vaccine Initiative on February, 2024 by the United States Patent and Trademark Office.	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	United States Patent and Trademark Office	11891416	February 6, 2024

23 results

0 selected

23 results

0 selected